Loading vulnerability…
CVE-2025-50675 affects GPMAW 14, a bioinformatics software package, due to insecure file permissions on its installation directory. The directory is configured with overly permissive read, write, and execute access for all local users, allowing unprivileged users to modify files stored there, including executable components such as GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. The core issue is that trusted application binaries in a privileged software directory can be replaced or altered by low-privileged users. An attacker can exploit this by substituting the uninstaller GPsetup64_17028.exe with a malicious executable. When an administrator later runs the uninstaller, the attacker-controlled binary executes in the administrator's security context, resulting in local privilege escalation and arbitrary code execution.
Mallory correlates every CVE against your assets, your vendors, and active adversary campaigns. Know which vulnerabilities matter for you, not just which ones are loud.
What it means. What to do now. Patch path, mitigations, and the assume-compromise checklist.
What an attacker gets, and what they’ve been doing with it.
If you can’t patch tonight, do this now.
Patch, then assume compromise.
No valid public exploits. Mallory filtered out 1 candidate as fakes, detection scripts, or README-only repos.
All candidate exploits were filtered out by Mallory's validation.
2 sources tracked across advisories and community write-ups. News coverage will land here when it surfaces.
No news coverage yet. Advisories and community discussion only.
Query your assets running an affected version, and investigate the blast radius.
Every observed campaign linking this CVE to a named adversary.
Malware families riding this exploit, with evidence and IOCs.
YARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Cross-references every affected SKU, including bundled OEM variants.
Community discussion across Reddit, Mastodon, and other social sources.